Drug Evaluation Committee Results of Questionnaire on Post-Marketing Surveillance for Pharmaceutical Companies
Pharmacovigilance Subcommittee
April 2026
The activities of pharmaceutical companies and the state of clinical practice are changing rapidly and dramatically with the development of information and communication technology, and companies are now using a variety of methods to provide information in post-marketing surveillance.
In addition, we believe that there is a need for post-marketing surveillance that balances the burden on healthcare professionals who receive information and its effect on safety measures.
In order to examine this issue, we conducted a questionnaire survey on the status of implementation of post-marketing surveillance by each company. We share the results of the survey for the reference of those who conduct or plan to conduct post-marketing surveillance at their respective companies.
We hope that the results of the survey will help your company plan and operate a useful and efficient post-marketing surveillance.
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
Pharmacovigilance Subcommittee Continuing Issues Team 8
Results of Questionnaire on Post-Marketing Surveillance for Pharmaceutical Companies